• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Reimbursement

Insulet Omnipod 5 picks up reimbursement in France

May 7, 2024 By Sean Whooley

Insulet Omnipod 5 Dexcom G6

Authorities in France say that the Insulet (Nasdaq:PODD) Omnipod 5 system now has reimbursement within the country. In a LinkedIn post, the Fédération Française des Diabetiques said it “welcomes the inclusion of Omnipod 5” on its list of reimbursable products and services. Omnipod 5, an insulin patch pump, delivers automated management for type 1 diabetes. […]

Filed Under: Business/Financial News, Diabetes, Featured, Regulatory/Compliance, Technology Tagged With: Insulet, Reimbursement

Analysts say high payor coverage, increased CGM adoption bodes well for Abbott, Dexcom

March 30, 2022 By Sean Whooley

Abbott FreeStyle Libre Dexcom G6

Analysts have suggested that companies like Abbott (NYSE:ABT) and Dexcom (Nasdaq:DXCM) may benefit from expected reimbursement progress. BTIG hosted a conference call with North Shore Medical Center (Salem, Massachusetts) Medical Director Dr. Gary Cohen and Healthcare Analytics, LLC analyst and consultant Dr. Joshua Cohen. The two experts offered insights into prescriber and patient interest in […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology, Wall Street Beat Tagged With: abbott, Centers for Medicare and Medicaid Services (CMS), CGM, Dexcom, Reimbursement

Japan approves expanded reimbursement coverage for Abbott’s FreeStyle Libre CGM

March 24, 2022 By Sean Whooley

Abbott FreeStyle Libre CGM

Abbott (NYSE:ABT) announced today that it received expanded reimbursement coverage in Japan for the FreeStyle Libre system. Japan’s Ministry of Health, Labour and Welfare approved the expansion for the continuous glucose monitoring (CGM) system to include all people with diabetes who use insulin at least once per day. Abbott Park, Illinois-based Abbott said the expanded […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Regulatory/Compliance Tagged With: abbott, Reimbursement

CMS expands Medicare coverage to CGMs that integrate with Medtronic insulin pumps

December 22, 2021 By Sean Whooley

Medtronic World Diabetes Day

Medtronic (NYSE:MDT) announced today that the U.S. Centers for Medicare & Medicaid Services (CMS) will expand coverage for CGMs. CMS’ expanded coverage covers all types of CGMs (continuous glucose monitors), including adjunctive and non-adjunctive CGMs, and it notably covers CGMs that integrate with Medtronic insulin pumps. According to a news release, the proposed rule was […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring Tagged With: Centers for Medicare and Medicaid Services (CMS), Medtronic, Reimbursement

EmblemHealth to provide coverage for Senseonics’ Eversense CGM

January 20, 2021 By Sean Whooley

Senseonics - updated logo

Senseonics (NYSE:SENS) announced that EmblemHealth is now providing coverage for its Eversense continuous glucose monitoring system. Germantown, Md.-based Senseonics said in a news release that the immediately effective decision adds to the number of payers writing the Eversense system into their CGM coverage policies and paying for the healthcare provider’s time for the in-office sensor placement. […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring Tagged With: Reimbursement, Senseonics

Senseonics touts Humana reimbursement nod for Eversense CGM

October 25, 2019 By Sean Whooley

eversense-logo

Senseonics (NYSE:SENS) said yesterday that Humana is now providing coverage for its Eversense continuous glucose monitoring system and insertion procedure. Humana is the fifth-largest health insurer in the U.S. with 17 million patients in 50 states, Washington, D.C. and Puerto Rico, according to a news release. Its coverage policy with Senseonics makes patients with Type 1 […]

Filed Under: Business/Financial News, Diabetes, Featured Tagged With: Humana, Reimbursement, Senseonics

Senseonics touts Eversense reimbursement win

October 16, 2019 By Sean Whooley

eversense-logo

Senseonics (NYSE:SENS) said this week that Health Care Service Corporation – Blue Cross Blue Shield is providing coverage for the Eversense continuous glucose monitoring system, effective as of yesterday. HCSC – Blue Cross Blue Shield is the fourth-largest health insurer in the U.S. and serves more than 16 million members, according to a news release. Last […]

Filed Under: Business/Financial News, Diabetes, Featured Tagged With: Reimbursement, Senseonics

Abbott wins FreeStyle Libre reimbursement in Ontario, Quebec

September 13, 2019 By Sean Whooley

Abbott logo updated

Abbott (NYSE:ABT) said today that it has won public reimbursement in Ontario and Quebec for its FreeStyle Libre sensor-based glucose monitoring system — the first of its kind listed by any provincial health plan in Canada. FreeStyle Libre is designed to monitor glucose levels with a small sensor on the back of the upper arm […]

Filed Under: Business/Financial News, Diabetes, Featured, Patient Monitoring, Wall Street Beat Tagged With: abbott, Reimbursement

Intersect ENT claims reimbursement win for Propel drug-eluting sinus implant

August 29, 2016 By Brad Perriello

Intersect ENT (NSDQ:XENT) said today that it won a positive coverage decision from CareFirst BlueCross BlueShield for its Propel and Propel Mini drug-eluting sinus implants. The devices are designed to elute the anti-inflammatory steroid mometasone furoate; Menlo Park, Calif.-based Intersect won FDA approval for the original Propel implant in August 2011 and for the Propel Mini the following September. The […]

Filed Under: Drug-Device Combinations Tagged With: Ear Nose & Throat (ENT), Intersect ENT Inc., Reimbursement

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS